Who
Daniel E. Pinto
Director
Company insider
Files Form 4 as: Director, Johnson & Johnson; Director, Intercontinental Exchange; President & COO, JP Morgan Chase & Co.
In numbers
- Trades disclosed
- 202
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $59.1M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 13 Jan 2013
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K113.098 at $276.31 | filing |
| 8 Sep 2026filed 10 Sep 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K113.1 at $276.31 | filing |
| 9 Jun 2026filed 11 Jun 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K134.241 at $232.79 | filing |
| 9 Jun 2026filed 11 Jun 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K134.24 at $232.79 | filing |
| 18 May 2026filed 20 May 2026 | ICE Intercontinental ExchangeExchanges & fin. data | SEC FORM 4 Code A | —1,538 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | ICE Intercontinental ExchangeExchanges & fin. data | SEC FORM 4 Code A | —1,538 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,712 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,712 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K129.058 at $242.14 | filing |
| 10 Mar 2026filed 12 Mar 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K129.06 at $242.14 | filing |
| 9 Dec 2025filed 11 Dec 2025 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K154.61 at $202.12 | filing |
| 9 Sep 2025filed 11 Sep 2025 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K175.49 at $178.07 | filing |
| 25 Mar 2025filed 27 Mar 2025 | JPM JP Morgan Chase & Cooption or derivative · Money-centre banks | SEC FORM 4 Code M | —19,524 at $0.00 | filing |
| 25 Mar 2025filed 27 Mar 2025 | JPM JP Morgan Chase & Cooption or derivative · Money-centre banks | SEC FORM 4 Code M | —23,442 at $0.00 | filing |
| 25 Mar 2025filed 27 Mar 2025 | JPM JP Morgan Chase & Cooption or derivative · Money-centre banks | SEC FORM 4 Code M | —17,826 at $0.00 | filing |
| 25 Mar 2025filed 27 Mar 2025 | JPM JP Morgan Chase & Cooption or derivative · Money-centre banks | SEC FORM 4 Code M | —20,904 at $0.00 | filing |
| 25 Mar 2025filed 27 Mar 2025 | JPM JP Morgan Chase & Cooption or derivative · Money-centre banks | SEC FORM 4 Code M | —22,688 at $0.00 | filing |
| 25 Mar 2025filed 27 Mar 2025 | JPM JP Morgan Chase & CoMoney-centre banks | SEC FORM 4 Code M | —23,442 at $0.00 | filing |
| 25 Mar 2025filed 27 Mar 2025 | JPM JP Morgan Chase & CoMoney-centre banks | SEC FORM 4 Code M | —22,688 at $0.00 | filing |
| 25 Mar 2025filed 27 Mar 2025 | JPM JP Morgan Chase & CoMoney-centre banks | SEC FORM 4 Code M | —20,904 at $0.00 | filing |
News
CoastalSouth Bancshares (NYSE:COSO) vs. JPMorgan Chase & Co. (NYSE:JPM) Head to Head ContrastJPM · themarketsdaily.com · 13 Oct 2026Financial Contrast: Commerce Bancshares (NASDAQ:CBSH) versus JPMorgan Chase & Co. (NYSE:JPM)JPM · dailypolitical.com · 12 Oct 2026Head-To-Head Contrast: Commerce Bancshares (NASDAQ:CBSH) and JPMorgan Chase & Co. (NYSE:JPM)JPM · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Daniel E. Pinto; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.